Relapsed/Refractory B Cell Malignancies
Also known as: Relapsed/Refractory B-cell Malignancies
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB15227 | Tirabrutinib | 1 | Completed | 1 |
| DB15299 | Navtemadlin | 1 / 2 | Active Not Recruiting | 1 |